Giulia Pinton

Giulia Pinton is an Associate Professor in the Department of Pharmaceutical Sciences at the University of Eastern Piedmont 'Amedeo Avogadro'. Her research focuses on cancer biology, particularly malignant pleural mesothelioma, epigenetic mechanisms, and drug development. She explores therapeutic targets such as ALDH1A3, EZH2, and estrogen receptors, with a focus on inhibiting tumor growth and improving treatment outcomes. Her work integrates pharmacology, molecular biology, and clinical implications.

Dr. Pinton leads and collaborates on projects addressing lipid homeostasis, cancer therapy resistance, and novel therapeutics for mesothelioma. Notable projects include ALTMeso (targeting ALDH1A3), epigenetic modulation of therapy resistance, and developing fluorescent probes for glioma diagnosis. Her research aligns with UN Sustainable Development Goals, particularly targeting health and well-being (Goal 3).

Her publications emphasize drug development, epigenetic regulation, and cellular mechanisms in cancer. Ongoing projects (2023–2025) focus on translational research with potential clinical applications. Her lab’s work spans both basic science and preclinical studies, contributing to precision oncology and novel therapeutic strategies.